COMBINATION TREATMENT WITH PROPIVERINE HYDROCHLORIDE PLUS DOXAZOSIN CONTROLLED RELEASE GASTROINTESTINAL THERAPEUTIC SYSTEM FORMULATION FOR OVERACTIVE BLADDER AND COEXISTING BENIGN PROSTATIC OBSTRUCTION: A PROSPECTIVE, RANDOMIZED, CONTROLLED MULTICENTER STUDY-Reference-Cited by-同舟云学术

COMBINATION TREATMENT WITH PROPIVERINE HYDROCHLORIDE PLUS DOXAZOSIN CONTROLLED RELEASE GASTROINTESTINAL THERAPEUTIC SYSTEM FORMULATION FOR OVERACTIVE BLADDER AND COEXISTING BENIGN PROSTATIC OBSTRUCTION: A PROSPECTIVE, RANDOMIZED, CONTROLLED MULTICENTER STUDY

Published:2005-10 Issue:4 Part 1 Volume:174 Page:1334-1338
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

LEE KYU-SUNG¹,CHOO MYUNG-SOO¹,KIM DUK-YOON¹,KIM JOON CHUL¹,KIM HYUNG-JEE¹,MIN KWEON SIK¹,LEE JONG BOUK¹,JEONG HEE JONG¹,LEE TACK¹,PARK WON HEE¹

Affiliation:

1. From the Departments of Urology, Sungkyunkwan University School of Medicine, University of Ulsan College of Medicine and Catholic University of Korea, Seoul, Catholic University of Daegu, Daegu, Dankook University College of Medicine, Chonan, Inje University School of Medicine, Busan, Gachon Medical School and Inha University College of Medicine, Incheon and Wonkwang University, Iksan, Korea

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. New words for old: lower urinary tract symptoms for “prostatism.”;Abrams;BMJ,1994

2. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society;Abrams;Neurourol Urodyn,2002

3. Prevalence and burden of overactive bladder in the United States;Stewart;World J Urol,2003

4. BPH with coexisting overactive bladder dysfunction—an everyday urological dilemma;Knutson;Neurourol Urodyn,2001

5. The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia;Chapple;Br J Urol,1994

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of an α₁‐blocker plus mirabegron compared with an α₁‐blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta‐analysis;Neurourology and Urodynamics;2024-01-30

2. Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms;European Urology;2023-08

3. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults;Cochrane Database of Systematic Reviews;2023-05-09

4. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

5. Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis;Journal of Urology;2023-02